Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson
Harvard Business School

Last Updated: December 14, 2019

DrugPatentWatch Database Preview

Litigation Details for Gilead Sciences, Inc. v. Teva Pharmaceuticals USA, Inc. (S.D.N.Y. 2010)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Gilead Sciences, Inc. v. Teva Pharmaceuticals USA, Inc. (S.D.N.Y. 2010)

Docket   Start Trial Date Filed 2010-03-05
Court District Court, S.D. New York Date Terminated 2013-02-20
Cause 35:271 Patent Infringement Assigned To Richard Joseph Sullivan
Jury Demand None Referred To
Patents 5,922,695; 5,935,946; 5,977,089; 6,043,230
Attorneys Christopher P. Borello; Colleen Tracy James; Daniel Peter Margolis; Daryl L Wiesen; David M. Hashmall; Elizabeth A. Gardner; Elizabeth J. Holland; Emily L. Rapalino; Frank P. Grassler; Frederick Millett; Gaudenis Vidugiris; George C. Lombardi; James Edward Nealon; James Wright Galbraith; Jason Elton Johnson; John Reynolds McNair; Jonathan Aaron Auerbach; Karen Chia-En Shen; Lorie Ann Morgan; Lynn M. Ulrich; Marc Joseph Pensabene; Margaret Anne O'Boyle; Maria Luisa Palmese; Michael Jeffrey Freno; Natalie Dana Lieber; Nicholas M. Cannella; Peter DeForest Shapiro; Peter Louis Giunta; Robert Seth Schwartz; Scott Alan McMurry; Simon David Roberts; Steven Khoa Le
Firms Fitzpatrick, Cella, Harper & Scinto; Fitzpatrick, Cella, Harper & Scinto(NYC); Gilead Sciences, Inc; Gilead Sciences, Inc.; Goodwin Procter, LLP (Boston); Goodwin Procter, LLP (NYC), the New York Times Building; Kelley Drye & Warren, LLP (CT); Kenyon & Kenyon LLP; Mayer Brown LLP (NY); O'Melveny and Myers LLP; Seed IP Law Group PLLC; Winston & Strawn LLP (IL); Winston and Strawn
Link to Docket External link to docket
Small Molecule Drugs cited in Gilead Sciences, Inc. v. Teva Pharmaceuticals USA, Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Gilead Sciences, Inc. v. Teva Pharmaceuticals USA, Inc. (S.D.N.Y. 2010)

Date Filed Document No. Description Snippet Link To Document
2010-03-05 1 trademark Atripla®. 16. United States Patent No. 5,922,695 (“the ’695 Patent,” copy attached as Exhibit A), …assigned the ’946 Patent to Gilead. _ COUNTI ' I_nfringement of U.S. Patent No._ 5,922,695 (ANDA No. 91…more claims of the ’230 Patent. C()UNT 9 Infringement of U.S. Patent No. 5,922,695 (ANDA No. 91-215) 86.…Action l. This is an action for patent infringement under the patent laws of the United States, Title…United States Patent and Trademark Office on¢July 13, 1999. The claims of the ’695 Patent cover, inter External link to document
2011-04-11 27 Exhibit A to Proposed Amended Complaint (USPN 5,922,695), # 3 Exhibit B to Proposed Amended Complaint … 20 February 2013 1:10-cv-01796 830 Patent None District Court, S.D. New External link to document
2012-10-09 81 STIPULATION AND AGREEMENT REGARDING U.S. PATENT NOS. 5,922,695, 5,935,946, 5,977,089 AND 6,043,230: Teva… '695 patent, (b) claims 1-4, 6 and 9 of the '946 patent, (c) claims 1 and 3 of the '089 patent, and (…1-4 of the '230 patent (all foregoing claims of the '695, '946, '089 and '230 patents are collectively… 20 February 2013 1:10-cv-01796 830 Patent None District Court, S.D. New External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.